Results 231 to 240 of about 188,451 (293)

PCN24 CHARACTERIZING RESOURCE USE AND TREATMENT COSTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE UNITED STATES (US)

, 2007
AR Levy, H Bavinton, Catherine H. Davis
openalex   +1 more source

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. [PDF]

Sci Rep
Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S.   +4 more
europepmc   +1 more source

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.

Blood, 2007
H. Kantarjian, F. Giles, N. Gattermann, K. Bhalla, G. Alimena, F. Palandri, G. Ossenkoppele, F. Nicolini, S. O’Brien, M. Litzow, R. Bhatia, F. Cervantes, A. Haque, Y. Shou, D. Resta, A. Weitzman, A. Hochhaus, P. le Coutre   +17 more
semanticscholar   +1 more source

Association of Nilotinib With Cardiovascular Diseases in Patients With Chronic Myelogenous Leukemia: A National Population-Based Cohort Study. [PDF]

Oncologist
Huang CE, Lee KD, Chang JJ, Tzeng HE, Huang SH, Yu LH, Chen MC.   +6 more
europepmc   +1 more source

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia

, 2015
Heriberto Bruzzoni‐Giovanelli, Juan R. González, François Sigaux, Bruno O. Villoutreix, Jean Michel Cayuela, Joëlle Guilhot, Claude Preudhomme, François Guilhot, Jean‐Luc Poyet, Philippe Rousselot   +9 more
openalex   +2 more sources

Numerical analysis of critical parameter values for remission during imatinib treatment of chronic myelogenous leukemia

Dana Paquin, L. Gross, Andrew Stewart, Giang Nguyễn Thái   +3 more
openalex   +1 more source

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations. [PDF]

Genes Dis
Zhang H, Zhong Y, He Y, Xu Y, Ren Y, Zhuang H, Sun T, Zhu Z, Mao X.   +8 more
europepmc   +1 more source